What's Changing Under the NDAA?
Add bookmark
We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
A key challenge in implementing the NDAA reform is doing so without obstructing the military's ability to maintain a "ready medical force and medically ready force." To maintain the military's ability, the DHA is utilizing recent technological advancements lifesaving innovations in an effort to modernize medical forces and facilities. In particular, the Biological Technologies Office within the Defense Advanced Research Projects Agency (DARPA) is currently researching biological technologies that will provide new tools for countering threats against our soldiers and country. This article explores what innovation is taking place with insight from Dr. Brad Ringeisen, Deputy Director of the Biological Technologies Office (BTO) at DARPA, who believes there is an urgent need to provide medical tools and technologies for military readiness.
